ARTICLE | Company News
BioStratum, NephroGenex, Vanderbilt University deal
May 15, 2006 7:00 AM UTC
BioStratum granted NephroGenex U.S. and European rights to diabetic neuropathy compound Pyridorin pyridoxamine for an undisclosed amount of cash and stock. The deal also includes BioStratum's second-...